Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

The latest research study released by Market IntelliX evaluates market size and forecasts of Stem Cells in Global, including the following market information:

Global Stem Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Stem Cells market was valued at 2832.7 million in 2021 and is projected to reach US$ 5673.4 million by 2028, at a CAGR of 10.4% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stem Cell Storage Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Stem Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Stem Cells Market Segment Percentages, by Type, 2021 (%)

Stem Cell Storage

Stem Cell Pharmaceutical and Treatment

Global Stem Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Stem Cells Market Segment Percentages, by Application, 2021 (%)

Blood Disease

Cancer

Autoimmune Disease

Others

Global Stem Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Stem Cells Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stem Cells revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Stem Cells revenues share in global market, 2021 (%)

The report presents profiles of competitors in the market Some of the prominent key players covered:

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi-post

JCR Pharmaceutical

MolMed

Pharmicell

Anterogen

Takeda (TiGenix)

CBR

ViaCord

Esperite

LifeCell

CCBC

VCANBIO

BOYA LIFE

Beike Biotechnology

International Medical

Global Cord Blood Corporation

Beijing Health-Biotech Group

ABMD

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Stem Cells Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Stem Cells Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Stem Cells Overall Market Size

2.1 Global Stem Cells Market Size: 2021 VS 2028

2.2 Global Stem Cells Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Stem Cells Players in Global Market

3.2 Top Global Stem Cells Companies Ranked by Revenue

3.3 Global Stem Cells Revenue by Companies

3.4 Top 3 and Top 5 Stem Cells Companies in Global Market, by Revenue in 2021

3.5 Global Companies Stem Cells Product Type

3.6 Tier 1, Tier 2 and Tier 3 Stem Cells Players in Global Market

3.6.1 List of Global Tier 1 Stem Cells Companies

3.6.2 List of Global Tier 2 and Tier 3 Stem Cells Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global Stem Cells Market Size Markets, 2021 & 2028

4.1.2 Stem Cell Storage

4.1.3 Stem Cell Pharmaceutical and Treatment

4.2 By Type - Global Stem Cells Revenue & Forecasts

4.2.1 By Type - Global Stem Cells Revenue, 2017-2022

4.2.2 By Type - Global Stem Cells Revenue, 2023-2028

4.2.3 By Type - Global Stem Cells Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global Stem Cells Market Size, 2021 & 2028

5.1.2 Blood Disease

5.1.3 Cancer

5.1.4 Autoimmune Disease

5.1.5 Others

5.2 By Application - Global Stem Cells Revenue & Forecasts

5.2.1 By Application - Global Stem Cells Revenue, 2017-2022

5.2.2 By Application - Global Stem Cells Revenue, 2023-2028

5.2.3 By Application - Global Stem Cells Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global Stem Cells Market Size, 2021 & 2028

6.2 By Region - Global Stem Cells Revenue & Forecasts

6.2.1 By Region - Global Stem Cells Revenue, 2017-2022

6.2.2 By Region - Global Stem Cells Revenue, 2023-2028

6.2.3 By Region - Global Stem Cells Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America Stem Cells Revenue, 2017-2028

6.3.2 US Stem Cells Market Size, 2017-2028

6.3.3 Canada Stem Cells Market Size, 2017-2028

6.3.4 Mexico Stem Cells Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe Stem Cells Revenue, 2017-2028

6.4.2 Germany Stem Cells Market Size, 2017-2028

6.4.3 France Stem Cells Market Size, 2017-2028

6.4.4 U.K. Stem Cells Market Size, 2017-2028

6.4.5 Italy Stem Cells Market Size, 2017-2028

6.4.6 Russia Stem Cells Market Size, 2017-2028

6.4.7 Nordic Countries Stem Cells Market Size, 2017-2028

6.4.8 Benelux Stem Cells Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia Stem Cells Revenue, 2017-2028

6.5.2 China Stem Cells Market Size, 2017-2028

6.5.3 Japan Stem Cells Market Size, 2017-2028

6.5.4 South Korea Stem Cells Market Size, 2017-2028

6.5.5 Southeast Asia Stem Cells Market Size, 2017-2028

6.5.6 India Stem Cells Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America Stem Cells Revenue, 2017-2028

6.6.2 Brazil Stem Cells Market Size, 2017-2028

6.6.3 Argentina Stem Cells Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa Stem Cells Revenue, 2017-2028

6.7.2 Turkey Stem Cells Market Size, 2017-2028

6.7.3 Israel Stem Cells Market Size, 2017-2028

6.7.4 Saudi Arabia Stem Cells Market Size, 2017-2028

6.7.5 UAE Stem Cells Market Size, 2017-2028

7 Players Profiles

7.1 Osiris Therapeutics

7.1.1 Osiris Therapeutics Corporate Summary

7.1.2 Osiris Therapeutics Business Overview

7.1.3 Osiris Therapeutics Stem Cells Major Product Offerings

7.1.4 Osiris Therapeutics Stem Cells Revenue in Global Market (2017-2022)

7.1.5 Osiris Therapeutics Key News

7.2 NuVasive

7.2.1 NuVasive Corporate Summary

7.2.2 NuVasive Business Overview

7.2.3 NuVasive Stem Cells Major Product Offerings

7.2.4 NuVasive Stem Cells Revenue in Global Market (2017-2022)

7.2.5 NuVasive Key News

7.3 Chiesi Pharmaceuticals

7.3.1 Chiesi Pharmaceuticals Corporate Summary

7.3.2 Chiesi Pharmaceuticals Business Overview

7.3.3 Chiesi Pharmaceuticals Stem Cells Major Product Offerings

7.3.4 Chiesi Pharmaceuticals Stem Cells Revenue in Global Market (2017-2022)

7.3.5 Chiesi Pharmaceuticals Key News

7.4 Medi-post

7.4.1 Medi-post Corporate Summary

7.4.2 Medi-post Business Overview

7.4.3 Medi-post Stem Cells Major Product Offerings

7.4.4 Medi-post Stem Cells Revenue in Global Market (2017-2022)

7.4.5 Medi-post Key News

7.5 JCR Pharmaceutical

7.5.1 JCR Pharmaceutical Corporate Summary

7.5.2 JCR Pharmaceutical Business Overview

7.5.3 JCR Pharmaceutical Stem Cells Major Product Offerings

7.5.4 JCR Pharmaceutical Stem Cells Revenue in Global Market (2017-2022)

7.5.5 JCR Pharmaceutical Key News

7.6 MolMed

7.6.1 MolMed Corporate Summary

7.6.2 MolMed Business Overview

7.6.3 MolMed Stem Cells Major Product Offerings

7.6.4 MolMed Stem Cells Revenue in Global Market (2017-2022)

7.6.5 MolMed Key News

7.7 Pharmicell

7.7.1 Pharmicell Corporate Summary

7.7.2 Pharmicell Business Overview

7.7.3 Pharmicell Stem Cells Major Product Offerings

7.7.4 Pharmicell Stem Cells Revenue in Global Market (2017-2022)

7.7.5 Pharmicell Key News

7.8 Anterogen

7.8.1 Anterogen Corporate Summary

7.8.2 Anterogen Business Overview

7.8.3 Anterogen Stem Cells Major Product Offerings

7.8.4 Anterogen Stem Cells Revenue in Global Market (2017-2022)

7.8.5 Anterogen Key News

7.9 Takeda (TiGenix)

7.9.1 Takeda (TiGenix) Corporate Summary

7.9.2 Takeda (TiGenix) Business Overview

7.9.3 Takeda (TiGenix) Stem Cells Major Product Offerings

7.9.4 Takeda (TiGenix) Stem Cells Revenue in Global Market (2017-2022)

7.9.5 Takeda (TiGenix) Key News

7.10 CBR

7.10.1 CBR Corporate Summary

7.10.2 CBR Business Overview

7.10.3 CBR Stem Cells Major Product Offerings

7.10.4 CBR Stem Cells Revenue in Global Market (2017-2022)

7.10.5 CBR Key News

7.11 ViaCord

7.11.1 ViaCord Corporate Summary

7.11.2 ViaCord Business Overview

7.11.3 ViaCord Stem Cells Major Product Offerings

7.11.4 ViaCord Stem Cells Revenue in Global Market (2017-2022)

7.11.5 ViaCord Key News

7.12 Esperite

7.12.1 Esperite Corporate Summary

7.12.2 Esperite Business Overview

7.12.3 Esperite Stem Cells Major Product Offerings

7.12.4 Esperite Stem Cells Revenue in Global Market (2017-2022)

7.12.5 Esperite Key News

7.13 LifeCell

7.13.1 LifeCell Corporate Summary

7.13.2 LifeCell Business Overview

7.13.3 LifeCell Stem Cells Major Product Offerings

7.13.4 LifeCell Stem Cells Revenue in Global Market (2017-2022)

7.13.5 LifeCell Key News

7.14 CCBC

7.14.1 CCBC Corporate Summary

7.14.2 CCBC Business Overview

7.14.3 CCBC Stem Cells Major Product Offerings

7.14.4 CCBC Stem Cells Revenue in Global Market (2017-2022)

7.14.5 CCBC Key News

7.15 VCANBIO

7.15.1 VCANBIO Corporate Summary

7.15.2 VCANBIO Business Overview

7.15.3 VCANBIO Stem Cells Major Product Offerings

7.15.4 VCANBIO Stem Cells Revenue in Global Market (2017-2022)

7.15.5 VCANBIO Key News

7.16 BOYA LIFE

7.16.1 BOYA LIFE Corporate Summary

7.16.2 BOYA LIFE Business Overview

7.16.3 BOYA LIFE Stem Cells Major Product Offerings

7.16.4 BOYA LIFE Stem Cells Revenue in Global Market (2017-2022)

7.16.5 BOYA LIFE Key News

7.17 Beike Biotechnology

7.17.1 Beike Biotechnology Corporate Summary

7.17.2 Beike Biotechnology Business Overview

7.17.3 Beike Biotechnology Stem Cells Major Product Offerings

7.17.4 Beike Biotechnology Stem Cells Revenue in Global Market (2017-2022)

7.17.5 Beike Biotechnology Key News

7.18 International Medical

7.18.1 International Medical Corporate Summary

7.18.2 International Medical Business Overview

7.18.3 International Medical Stem Cells Major Product Offerings

7.18.4 International Medical Stem Cells Revenue in Global Market (2017-2022)

7.18.5 International Medical Key News

7.19 Global Cord Blood Corporation

7.19.1 Global Cord Blood Corporation Corporate Summary

7.19.2 Global Cord Blood Corporation Business Overview

7.19.3 Global Cord Blood Corporation Stem Cells Major Product Offerings

7.19.4 Global Cord Blood Corporation Stem Cells Revenue in Global Market (2017-2022)

7.19.5 Global Cord Blood Corporation Key News

7.20 Beijing Health-Biotech Group

7.20.1 Beijing Health-Biotech Group Corporate Summary

7.20.2 Beijing Health-Biotech Group Business Overview

7.20.3 Beijing Health-Biotech Group Stem Cells Major Product Offerings

7.20.4 Beijing Health-Biotech Group Stem Cells Revenue in Global Market (2017-2022)

7.20.5 Beijing Health-Biotech Group Key News

7.21 ABMD

7.21.1 ABMD Corporate Summary

7.21.2 ABMD Business Overview

7.21.3 ABMD Stem Cells Major Product Offerings

7.21.4 ABMD Stem Cells Revenue in Global Market (2017-2022)

7.21.5 ABMD Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Tables

Table 1. Stem Cells Market Opportunities & Trends in Global Market

Table 2. Stem Cells Market Drivers in Global Market

Table 3. Stem Cells Market Restraints in Global Market

Table 4. Key Players of Stem Cells in Global Market

Table 5. Top Stem Cells Players in Global Market, Ranking by Revenue (2021)

Table 6. Global Stem Cells Revenue by Companies, (US$, Mn), 2017-2022

Table 7. Global Stem Cells Revenue Share by Companies, 2017-2022

Table 8. Global Companies Stem Cells Product Type

Table 9. List of Global Tier 1 Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Stem Cells Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Stem Cells Revenue in Global (US$, Mn), 2017-2022

Table 13. By Type - Stem Cells Revenue in Global (US$, Mn), 2023-2028

Table 14. By Application – Global Stem Cells Revenue, (US$, Mn), 2021 & 2028

Table 15. By Application - Stem Cells Revenue in Global (US$, Mn), 2017-2022

Table 16. By Application - Stem Cells Revenue in Global (US$, Mn), 2023-2028

Table 17. By Region – Global Stem Cells Revenue, (US$, Mn), 2021 & 2028

Table 18. By Region - Global Stem Cells Revenue (US$, Mn), 2017-2022

Table 19. By Region - Global Stem Cells Revenue (US$, Mn), 2023-2028

Table 20. By Country - North America Stem Cells Revenue, (US$, Mn), 2017-2022

Table 21. By Country - North America Stem Cells Revenue, (US$, Mn), 2023-2028

Table 22. By Country - Europe Stem Cells Revenue, (US$, Mn), 2017-2022

Table 23. By Country - Europe Stem Cells Revenue, (US$, Mn), 2023-2028

Table 24. By Region - Asia Stem Cells Revenue, (US$, Mn), 2017-2022

Table 25. By Region - Asia Stem Cells Revenue, (US$, Mn), 2023-2028

Table 26. By Country - South America Stem Cells Revenue, (US$, Mn), 2017-2022

Table 27. By Country - South America Stem Cells Revenue, (US$, Mn), 2023-2028

Table 28. By Country - Middle East & Africa Stem Cells Revenue, (US$, Mn), 2017-2022

Table 29. By Country - Middle East & Africa Stem Cells Revenue, (US$, Mn), 2023-2028

Table 30. Osiris Therapeutics Corporate Summary

Table 31. Osiris Therapeutics Stem Cells Product Offerings

Table 32. Osiris Therapeutics Stem Cells Revenue (US$, Mn), (2017-2022)

Table 33. NuVasive Corporate Summary

Table 34. NuVasive Stem Cells Product Offerings

Table 35. NuVasive Stem Cells Revenue (US$, Mn), (2017-2022)

Table 36. Chiesi Pharmaceuticals Corporate Summary

Table 37. Chiesi Pharmaceuticals Stem Cells Product Offerings

Table 38. Chiesi Pharmaceuticals Stem Cells Revenue (US$, Mn), (2017-2022)

Table 39. Medi-post Corporate Summary

Table 40. Medi-post Stem Cells Product Offerings

Table 41. Medi-post Stem Cells Revenue (US$, Mn), (2017-2022)

Table 42. JCR Pharmaceutical Corporate Summary

Table 43. JCR Pharmaceutical Stem Cells Product Offerings

Table 44. JCR Pharmaceutical Stem Cells Revenue (US$, Mn), (2017-2022)

Table 45. MolMed Corporate Summary

Table 46. MolMed Stem Cells Product Offerings

Table 47. MolMed Stem Cells Revenue (US$, Mn), (2017-2022)

Table 48. Pharmicell Corporate Summary

Table 49. Pharmicell Stem Cells Product Offerings

Table 50. Pharmicell Stem Cells Revenue (US$, Mn), (2017-2022)

Table 51. Anterogen Corporate Summary

Table 52. Anterogen Stem Cells Product Offerings

Table 53. Anterogen Stem Cells Revenue (US$, Mn), (2017-2022)

Table 54. Takeda (TiGenix) Corporate Summary

Table 55. Takeda (TiGenix) Stem Cells Product Offerings

Table 56. Takeda (TiGenix) Stem Cells Revenue (US$, Mn), (2017-2022)

Table 57. CBR Corporate Summary

Table 58. CBR Stem Cells Product Offerings

Table 59. CBR Stem Cells Revenue (US$, Mn), (2017-2022)

Table 60. ViaCord Corporate Summary

Table 61. ViaCord Stem Cells Product Offerings

Table 62. ViaCord Stem Cells Revenue (US$, Mn), (2017-2022)

Table 63. Esperite Corporate Summary

Table 64. Esperite Stem Cells Product Offerings

Table 65. Esperite Stem Cells Revenue (US$, Mn), (2017-2022)

Table 66. LifeCell Corporate Summary

Table 67. LifeCell Stem Cells Product Offerings

Table 68. LifeCell Stem Cells Revenue (US$, Mn), (2017-2022)

Table 69. CCBC Corporate Summary

Table 70. CCBC Stem Cells Product Offerings

Table 71. CCBC Stem Cells Revenue (US$, Mn), (2017-2022)

Table 72. VCANBIO Corporate Summary

Table 73. VCANBIO Stem Cells Product Offerings

Table 74. VCANBIO Stem Cells Revenue (US$, Mn), (2017-2022)

Table 75. BOYA LIFE Corporate Summary

Table 76. BOYA LIFE Stem Cells Product Offerings

Table 77. BOYA LIFE Stem Cells Revenue (US$, Mn), (2017-2022)

Table 78. Beike Biotechnology Corporate Summary

Table 79. Beike Biotechnology Stem Cells Product Offerings

Table 80. Beike Biotechnology Stem Cells Revenue (US$, Mn), (2017-2022)

Table 81. International Medical Corporate Summary

Table 82. International Medical Stem Cells Product Offerings

Table 83. International Medical Stem Cells Revenue (US$, Mn), (2017-2022)

Table 84. Global Cord Blood Corporation Corporate Summary

Table 85. Global Cord Blood Corporation Stem Cells Product Offerings

Table 86. Global Cord Blood Corporation Stem Cells Revenue (US$, Mn), (2017-2022)

Table 87. Beijing Health-Biotech Group Corporate Summary

Table 88. Beijing Health-Biotech Group Stem Cells Product Offerings

Table 89. Beijing Health-Biotech Group Stem Cells Revenue (US$, Mn), (2017-2022)

Table 90. ABMD Corporate Summary

Table 91. ABMD Stem Cells Product Offerings

Table 92. ABMD Stem Cells Revenue (US$, Mn), (2017-2022)

List of Figures

Figure 1. Stem Cells Segment by Type in 2021

Figure 2. Stem Cells Segment by Application in 2021

Figure 3. Global Stem Cells Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Stem Cells Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Stem Cells Revenue, 2017-2028 (US$, Mn)

Figure 7. The Top 3 and 5 Players Market Share by Stem Cells Revenue in 2021

Figure 8. By Type - Global Stem Cells Revenue Market Share, 2017-2028

Figure 9. By Application - Global Stem Cells Revenue Market Share, 2017-2028

Figure 10. By Region - Global Stem Cells Revenue Market Share, 2017-2028

Figure 11. By Country - North America Stem Cells Revenue Market Share, 2017-2028

Figure 12. US Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 13. Canada Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 14. Mexico Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 15. By Country - Europe Stem Cells Revenue Market Share, 2017-2028

Figure 16. Germany Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 17. France Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 18. U.K. Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 19. Italy Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 20. Russia Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 21. Nordic Countries Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 22. Benelux Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 23. By Region - Asia Stem Cells Revenue Market Share, 2017-2028

Figure 24. China Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 25. Japan Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 26. South Korea Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 27. Southeast Asia Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 28. India Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 29. By Country - South America Stem Cells Revenue Market Share, 2017-2028

Figure 30. Brazil Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 31. Argentina Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 32. By Country - Middle East & Africa Stem Cells Revenue Market Share, 2017-2028

Figure 33. Turkey Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 34. Israel Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 35. Saudi Arabia Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 36. UAE Stem Cells Revenue, (US$, Mn), 2017-2028

Figure 37. Osiris Therapeutics Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 38. NuVasive Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 39. Chiesi Pharmaceuticals Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 40. Medi-post Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 41. JCR Pharmaceutical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 42. MolMed Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 43. Pharmicell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 44. Anterogen Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 45. Takeda (TiGenix) Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 46. CBR Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 47. ViaCord Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 48. Esperite Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 49. LifeCell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 50. CCBC Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 51. VCANBIO Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 52. BOYA LIFE Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 53. Beike Biotechnology Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 54. International Medical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 55. Global Cord Blood Corporation Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 56. Beijing Health-Biotech Group Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 57. ABMD Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)